GGT5 and gastric cancer: To validate the result in the TCGA cohort, we collected 200 GC patients from GSE15459; it shows that high GGT5 expression group had a significantly worse OS than the low GGT5 expression group (Fig. S3a, p = 0.00035, HR (95% CI) 0.49(0.32–0.76)).